Concepedia

Valerie Dyer

VD

5

Publications

311

Citations

5

H-Index

1999

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

National Institutes of Health Clinical Center

Valerie Dyer is an author at National Cancer Institute specializing in oncology, urology, and cancer therapeutics.

Top concepts

Publications per year

1999–2001

5

Publications

5

Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Michelle A. Rudek, William D. Figg, Valerie Dyer et al. · Journal of Clinical Oncology · 2001 · 157 citations

A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer.

Kenneth S. Bauer, William D. Figg, J M Hamilton et al. · PubMed · 1999 · 59 citations

, , +12

Drug-induced lupus associated with COL-3: report of 3 cases.

Jayashri V. Ghate, Maria L. Turner, Michelle A. Rudek et al. · PubMed · 2001 · 48 citations

Reversible sideroblastic anemia associated with the tetracycline analogue COL‐3

Michelle A. Rudek, McDonald K. Horne, William D. Figg et al. · American Journal of Hematology · 2001 · 25 citations

Alendronate does not interfere with 99mTc-methylene diphosphonate bone scanning.

Jorge A. Carrasquillo, Millie Whatley, Valerie Dyer et al. · PubMed · 2001 · 22 citations

Rows per page

1–5 of 5